Jazz Pharmaceuticals plc JAZZ
Set alert
232.00 USD +17.56 +8.19%
As of Nov 3, 12:12 PM ET
218.53 Day range 233.74
131.16 52-week range 261.62
- YTD
- +36.47%
- 1 year
- +67.66%
- Open
- 225.37
- Prev close
- 214.44
- Mkt cap
- 15.05B
- Vol
- 634.93K
- Avg vol
- 892.51K
- EPS
- 3.38
- P/E
- 68.62
- Div yield
- 0.00%
More statistics
- Low
- 218.53
- High
- 233.74
- Forward P/E
- 8.51
- Beta
- 0.37
- Short ratio
- 6.86
- Inst. own
- 103.88%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 23, 2027
- 50-d avg
- 231.96
- 200-d avg
- 216.63
- 1y target
- 295.36
6M chart
Events in this range
- May 5, 2026Earnings: 6.34; estimate 4.64; surprise 36.64%
- Aug 3, 2026Earnings: 5.71; estimate 6.18; surprise -7.61%
- Sep 11, 2026Rating: UBS · Buy → Buy
- Sep 30, 2026Rating: Citigroup · — → Buy
- Oct 7, 2026Rating: Truist Securities · Buy → Buy
- Oct 8, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 21, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 28, 2026Rating: JP Morgan · Overweight → Overweight
- Nov 2, 2026Earnings: -3.88; estimate -4.05; surprise 4.2%
Signals (23)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 2026 | 2 hours ago |
| MACD: Buy Signal | Oct 29, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 26, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 30, 2026 | 4 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| RSI: Overbought | May 19, 2026 | 5 months ago |
Newest 20 of 23.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 295.36 +27.3% upside
Now 232.00
- Target (low)
- 225.00
- Target (mean)
- 295.36
- Target (high)
- 337.00
Ratings (0m) 22 20 buy · 2 hold · 0 sell
- Strong buy7
- Buy13
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 22
- 1 month ago 22
- 2 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.38 | -4.72 – 5.81 | 8.13 | -129.2% | 1.21B | +7.7% | 13 |
| Next quarter | 6.56 | 5.16 – 8.78 | 6.64 | -1.3% | 1.24B | +3.8% | 13 |
| Current year | 15.49 | 13.35 – 24.00 | 8.38 | +84.9% | 4.74B | +11.0% | 13 |
| Next year | 25.20 | 13.70 – 31.39 | 15.49 | +62.6% | 5.02B | +5.9% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 21, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Sep 30, 2026 | Citigroup | Initiated | — | Buy |
| Sep 11, 2026 | UBS | Maintained | Buy | Buy |
| Sep 10, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 26, 2026 | Deutsche Bank | Maintained | Buy | Buy |
| Aug 26, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 26, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 26, 2026 | Needham | Maintained | Buy | Buy |
| Aug 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 4, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 4, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 4, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Needham | Maintained | Buy | Buy |
| Aug 4, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Baird | Maintained | Outperform | Outperform |
| Jul 20, 2026 | Needham | Maintained | Buy | Buy |
| Jul 17, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Jul 14, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 9, 2026 | Deutsche Bank | Maintained | Buy | Buy |
| Jul 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jun 10, 2026 | B of A Securities | Maintained | Buy | Buy |
| May 27, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 22, 2026 | Bernstein | Initiated | — | Market Perform |